Fructose injection of antibiotic drug

A technology for antibiotics and injections, applied in the field of medicine, can solve problems such as reducing the scope of use, and achieve the effects of fast onset, expansion of the scope of use, and ease of use

Inactive Publication Date: 2017-05-17
威海恒基伟业信息科技发展有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] For drugs used by injection, especially antibiotic glucose injection drugs, glucose solution is used as a drug carrier, which is oxidized into carbon dioxide and water in the body, and at the same time supplies energy, or is stored in the form of glycogen, which has the functions of detoxification, The role of liver protection, which is a good rehabilitation support for patients, is conducive to the recovery of body functions and reduces the toxic and side effects of drugs; but because the metabolism of glucose in the body needs to consume insulin, it is not suitable for diabetic patients and those with abnormal glucose tolerance. , greatly reducing the scope of its use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1. lomefloxacin hydrochloride fructose injection

[0024] Take an appropriate amount of fructose and add it to an appropriate amount of water for injection to dissolve completely, then add an appropriate amount of activated carbon for needles, stir well, adjust the pH value to 4-4.5 with hydrochloric acid solution, keep it warm at 90°C for 30 minutes, filter while hot to remove the activated carbon; Add an appropriate amount of lomefloxacin hydrochloride to the above fructose filtrate, add water for injection to the full amount, stir evenly, seal the jar with fine filter, sterilize by autoclaving at 115°C for 30 minutes, test and inspect, and pack.

[0025] In the above preparation process, activated carbon is used to adsorb pyrogens and decolorize, and activated carbon is not a component of the injection; in addition, injections with different concentrations can be prepared by controlling the dosage of lomefloxacin hydrochloride and fructose, for example, eac...

Embodiment 2

[0027] Embodiment 2. Ornidazole fructose injection

[0028] Weigh 5 grams of ornidazole and add about 900 ml of water for injection to dissolve, add 50 grams of fructose, stir until completely dissolved, adjust the pH value to about 4.5 with dilute hydrochloric acid, add 0.05% activated carbon for needles, and keep warm for 15 minutes at about 50 ° C. Decarbonize and filter while it is hot, add water for injection to 1000ml, measure the content and pH value of the solution, then fine filter with a 0.45 micron microporous membrane, fill and seal in a 100ml infusion bottle with nitrogen, and sterilize by hot pressing at 115°C 30 minutes, each bottle contains 0.5g ornidazole, 5.0g

[0029] The ornidazole fructose injection consists of ornidazole, fructose, hydrochloric acid, nitrogen and water, wherein the hydrochloric acid and nitrogen are additives, which are respectively pH regulator and protective gas.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a fructose injection of an antibiotic drug. The injection is composed of antibiotics, fructose and water. The injection also can contain proper additives. The antibiotic comprise gatifloxacin, levofloxacin, ofloxacin, ciprofloxacin, pazufloxacin, fleroxacin, sparfloxacin, moxifloxacin, pefloxacin, rufloxacin, lomefloxacin, norfloxacin, caderofloxacin, azithromycin, telithromycin, ornidazole, secnidazole, tinidazole, metronidazole, clindamycin, lincomycin, fluconazole, etimicin, netilmicin, amikacin and medicinal acid additive salts, esterified compounds, derivatives and the like. The antibiotics are prepared into the fructose injection. Besides the advantages of convenience in use and quickness to take effect of the injection, compared with a gluconic infection, the injection provided by the invention is more easily absorbed and utilized, is more suitable for preventing bacteria and diminishing inflammation, supplying energy and supplementing body fluids for patients with diabetes, heart disease and liver disease, so that the application range of the injection is expanded.

Description

technical field [0001] The invention belongs to the field of medical technology, and relates to a series of fructose injection injection medicines of antibiotic medicines. Background technique [0002] Injection is a type of liquid injection. Drugs enter human blood vessels, tissues or organs directly in liquid form. Drugs are absorbed quickly and act quickly. They are very suitable for rescuing critically ill patients and patients who are not suitable for oral administration. [0003] Antibiotics are antimicrobial drugs widely used clinically, especially antibiotic injection drugs. In clinical use, glucose or sodium chloride solution is often used as a carrier for injection with antibiotic drugs, such as levofloxacin lactate glucose injection, Oxen Nitazole Sodium Chloride Injection, etc. In addition to regulating osmotic pressure, the glucose and sodium chloride in the injection can also correct the disturbance of water and electrolytes in the body, and regulate the acid-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K9/08A61K47/26A61P31/04
CPCA61K45/00A61K9/0019A61K9/08A61K47/26
Inventor 蔡颖
Owner 威海恒基伟业信息科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products